selected scholarly activity
-
academic article
- Association Between Oxygen Saturation Targeting and Death or Disability in Extremely Preterm Infants in the Neonatal Oxygenation Prospective Meta-analysis Collaboration. JAMA - Journal of the American Medical Association. 319:2190-2190. 2018
- Association between prophylactic indomethacin and death or bronchopulmonary dysplasia: A systematic review and meta-analysis of observational studies. Seminars in Perinatology. 42:228-234. 2018
- Comparing Like with Like When Reporting Neurodevelopmental Outcomes after Preterm Birth. Journal of Pediatrics. 197:10-12. 2018
- Neurobehavioral Outcomes 11 Years After Neonatal Caffeine Therapy for Apnea of Prematurity. Pediatrics. 141:e20174047-e20174047. 2018
- Effect of Prophylactic Indomethacin in Extremely Low Birth Weight Infants Based on the Predicted Risk of Severe Intraventricular Hemorrhage. Biology of the Neonate Neonatology. 113:183-186. 2018
- Mortality and pulmonary outcomes of extremely preterm infants exposed to antenatal corticosteroids. American Journal of Obstetrics and Gynecology. 218:130.e1-130.e13. 2018
- Neonatal outcomes of moderately preterm infants compared to extremely preterm infants. Pediatric Research. 82:297-304. 2017
- Association between Use of Prophylactic Indomethacin and the Risk for Bronchopulmonary Dysplasia in Extremely Preterm Infants. Journal of Pediatrics. 186:34-40.e2. 2017
- Oxygen Targeting in Infants Born Extremely Preterm Who Are Small for Gestational Age: A Need for Heightened Vigilance. Journal of Pediatrics. 186:9-10. 2017
- Academic Performance, Motor Function, and Behavior 11 Years After Neonatal Caffeine Citrate Therapy for Apnea of Prematurity. JAMA Pediatrics. 171:564-564. 2017
- Neurodevelopmental Outcomes Following Surgical Ligation for Patent Ductus Arteriosus Among Extremely Preterm Infants. JAMA Pediatrics. 171:422-422. 2017
- Benefits of Oxygen Saturation Targeting Trials: Oximeter Calibration Software Revision and Infant Saturations. Journal of Pediatrics. 182:382-384. 2017
- The Effect of Skin Pigmentation on the Accuracy of Pulse Oximetry in Infants with Hypoxemia. Journal of Pediatrics. 182:375-377.e2. 2017
- Effects of Targeting Higher or Lower Oxygen Saturations in Centers with More Versus Less Separation between Median Saturations. Journal of Pediatrics. 178:288-291.e2. 2016
- Interobserver Reliability of the Respiratory Physical Examination in Premature Infants: A Multicenter Study. Journal of Pediatrics. 178:87-92. 2016
- Methodological issues in the design and analyses of neonatal research studies: Experience of the NICHD Neonatal Research Network. Seminars in Perinatology. 40:374-384. 2016
- Evidence-Based Pharmacologic Therapies for Prevention of Bronchopulmonary Dysplasia. Clinics in Perinatology. 42:755-779. 2015
- The ethics of neonatal research: A trialists' perspective. Seminars in Fetal and Neonatal Medicine Seminars in Neonatology. 20:431-435. 2015
- Prediction of Late Death or Disability at Age 5 Years Using a Count of 3 Neonatal Morbidities in Very Low Birth Weight Infants. Journal of Pediatrics. 167:982-986.e2. 2015
- Association Between Intermittent Hypoxemia or Bradycardia and Late Death or Disability in Extremely Preterm Infants. JAMA - Journal of the American Medical Association. 314:595-595. 2015
- Predicting severe motor impairment in preterm children at age 5 years. Archives of Disease in Childhood. 100:748-753. 2015
- Short-term Outcomes of Infants Enrolled in Randomized Clinical Trials vs Those Eligible but Not Enrolled. JAMA - Journal of the American Medical Association. 313:2377-2377. 2015
- Social Variables Predict Gains in Cognitive Scores across the Preschool Years in Children with Birth Weights 500 to 1250 Grams. Journal of Pediatrics. 166:870-876.e2. 2015
- Accuracy of Bayley Scores as Outcome Measures in Trials of Neonatal Therapies. JAMA Pediatrics. 169:188-188. 2015
- Impact of Study Oximeter Masking Algorithm on Titration of Oxygen Therapy in the Canadian Oxygen Trial. Journal of Pediatrics. 165:666-671.e2. 2014
- Reduction in Developmental Coordination Disorder with Neonatal Caffeine Therapy. Journal of Pediatrics. 165:356-359.e2. 2014
- Honesty, Trust, and Respect During Consent Discussions in Neonatal Clinical Trials. Pediatrics. 134:e1-e3. 2014
- Trade-Off between Lower or Higher Oxygen Saturations for Extremely Preterm Infants: The First Benefits of Oxygen Saturation Targeting (BOOST) II Trial Reports Its Primary Outcome. Journal of Pediatrics. 165:6-8. 2014
- Timing of Caffeine Therapy in Very Low Birth Weight Infants. Journal of Pediatrics. 164:957-958. 2014
- Definitions of extubation success in very premature infants: a systematic review. Archives of Disease in Childhood: Fetal and Neonatal Edition. 99:F124-F127. 2014
- Epidemiology of bronchopulmonary dysplasia. Birth Defects Research Part A - Clinical and Molecular Teratology Teratology. 100:145-157. 2014
- Association Between Severe Retinopathy of Prematurity and Nonvisual Disabilities at Age 5 Years. JAMA - Journal of the American Medical Association. 311:523-523. 2014
- Improving Delivery Room Management for Very Preterm Infants. Pediatrics. 132:e1018-e1025. 2013
- Serial echocardiography in very preterm infants: a pilot randomized trial. Acta Paediatrica, International Journal of Paediatrics. 102:n/a-n/a. 2013
- Effects of Targeting Higher vs Lower Arterial Oxygen Saturations on Death or Disability in Extremely Preterm Infants. JAMA - Journal of the American Medical Association. 309:2111-2111. 2013
- Nurse-to-Patient Ratios and Neonatal Outcomes: A Brief Systematic Review. Biology of the Neonate Neonatology. 104:179-183. 2013
- Survival Without Disability to Age 5 Years After Neonatal Caffeine Therapy for Apnea of Prematurity. Obstetrical and Gynecological Survey. 67:269-270. 2012
- Cognitive outcome at 24months is more predictive than at 18months for IQ at 8–9years in extremely low birth weight children. Early Human Development. 88:95-98. 2012
- Relationship Between Attrition and Neurodevelopmental Impairment Rates in Extremely Preterm Infants at 18 to 24 Months. Archives of Pediatrics and Adolescent Medicine. 166:178-178. 2012
- Survival Without Disability to Age 5 Years After Neonatal Caffeine Therapy for Apnea of Prematurity. JAMA - Journal of the American Medical Association. 307:275-275. 2012
- NeOProM: Neonatal Oxygenation Prospective Meta-analysis Collaboration study protocol. BMC Pediatrics. 11:6. 2011
- Impact of Delivery Room Resuscitation on Outcomes up to 18 Months in Very Low Birth Weight Infants. Journal of Pediatrics. 159:546-550.e1. 2011
- Quality of Reporting of Neonatal and Infant Trials in High-Impact Journals. Pediatrics. 128:e639-e644. 2011
- Archimedes: does caffeine treatment for apnoea of prematurity improve neurodevelopmental outcome in later life?. Archives of Disease in Childhood. 96:784-784. 2011
- Effects of Prophylactic Indomethacin in Extremely Low-Birth-Weight Infants With and Without Adequate Exposure to Antenatal Corticosteroids. Archives of Pediatrics and Adolescent Medicine. 165:642-642. 2011
- Why would a sane clinician not prescribe prophylactic indomethacin?. Acta Paediatrica, International Journal of Paediatrics. 100:636-636. 2011
- Economic Evaluation of Caffeine for Apnea of Prematurity. Pediatrics. 127:e146-e155. 2011
- Nurses’ compliance with alarm limits for pulse oximetry: qualitative study. Journal of Perinatology. 30:531-534. 2010
- Caffeine for Apnea of Prematurity Trial: Benefits May Vary in Subgroups. Journal of Pediatrics. 156:382-387.e3. 2010
- Periocular Ulcerative Dermatitis Associated with Gentamicin Ointment Prophylaxis in Newborns. Journal of Pediatrics. 156:320-321. 2010
- Using a Count of Neonatal Morbidities to Predict Poor Outcome in Extremely Low Birth Weight Infants: Added Role of Neonatal Infection. Pediatrics. 123:313-318. 2009
- Prevention and 18-Month Outcomes of Serious Pulmonary Hemorrhage in Extremely Low Birth Weight Infants: Results From the Trial of Indomethacin Prophylaxis in Preterms. Pediatrics. 121:e233-e238. 2008
- Evidence-Based Neonatal Drug Therapy for Prevention of Bronchopulmonary Dysplasia in Very-Low-Birth-Weight Infants. Biology of the Neonate Neonatology. 93:284-287. 2008
- Serum and Glucocorticoid-Inducible Kinase in Pulmonary Tissue of Preterm Fetuses Exposed to Chorioamnionitis. Biology of the Neonate Neonatology. 93:257-262. 2008
- Long-Term Effects of Caffeine Therapy for Apnea of Prematurity. New England Journal of Medicine. 357:1893-1902. 2007
- Preemie abandonment? Multidisciplinary experts consider how to best meet preemies needs at "preterm infants: a collaborative approach to specialized care" roundtable.. Modern Healthcare. 37:17-24. 2007
- Neurosensory Impairment after Surgical Closure of Patent Ductus Arteriosus in Extremely Low Birth Weight Infants: Results from the Trial of Indomethacin Prophylaxis in Preterms. Journal of Pediatrics. 150:229-234.e1. 2007
- Antithrombin for respiratory distress syndrome in preterm infants. Cohrane Library Clinical Respiratory Journal. CD005383. 2006
- Caffeine for apnea of prematurity - Reply. New England Journal of Medicine. 355:959-960. 2006
- Indomethacin prophylaxis, patent ductus arteriosus, and the risk of bronchopulmonary dysplasia: Further analyses from the Trial of Indomethacin Prophylaxis in Preterms (TIPP). Journal of Pediatrics. 148:730-734.e1. 2006
- Caffeine Therapy for Apnea of Prematurity. New England Journal of Medicine. 354:2112-2121. 2006
- Early prediction of poor outcome in extremely low birth weight infants by classification tree analysis. Journal of Pediatrics. 148:438-444.e1. 2006
- Antithrombin replacement in neonates: Is there any indication?. Thrombosis Research. 118:107-111. 2006
- Antithrombin replacement in neonates: Is there any indication?. Thrombosis Research. 118:107-111. 2006
- Male/Female Differences in Indomethacin Effects in Preterm Infants. Journal of Pediatrics. 147:860-862. 2005
- Reply. Journal of Pediatrics. 147:717-717. 2005
- Methylxanthine Therapy for Apnea of Prematurity: Evaluation of Treatment Benefits and Risks at Age 5 Years in the International Caffeine for Apnea of Prematurity (CAP) Trial. Biology of the Neonate Neonatology. 88:208-213. 2005
- Heat Loss Prevention (HeLP) in the delivery room: A randomized controlled trial of polyethylene occlusive skin wrapping in very preterm infants. Journal of Pediatrics. 145:750-753. 2004
- Controversies surrounding xanthine therapy. Seminars in Fetal and Neonatal Medicine Seminars in Neonatology. 9:239-244. 2004
- Pulmonary 18Fluorodeoxyglucose uptake in infants of very low birth weight with and without intrauterine inflammation. Journal of Pediatrics. 143:470-476. 2003
-
Impact of Bronchopulmonary Dysplasia, Brain Injury, and Severe Retinopathy on the Outcome of Extremely Low-Birth-Weight Infants at 18 Months
Results From the Trial of Indomethacin Prophylaxis in Preterms . JAMA - Journal of the American Medical Association. 289:1124-1124. 2003 - Ibuprofen prophylaxis in preterm neonates. The Lancet. 360:492-492. 2002
- Evaluating “old” definitions for the “new” bronchopulmonary dysplasia. Journal of Pediatrics. 140:555-560. 2002
- Evidence-based neonatology: making a difference beyond discharge from the neonatal nursery. Current Opinion in Pediatrics. 14:165-169. 2002
- Accuracy of Doppler echocardiography for the diagnosis of thrombosis associated with umbilical venous catheters. Journal of Pediatrics. 140:131-134. 2002
- Spotting trends in the outcomes of neonatal intensive care. Journal of Pediatrics. 139:761-763. 2001
- Transport risk index of physiologic stability: A practical system for assessing infant transport care. Journal of Pediatrics. 139:220-226. 2001
- Long-Term Effects of Indomethacin Prophylaxis in Extremely-Low-Birth-Weight Infants. New England Journal of Medicine. 344:1966-1972. 2001
- Do we measure the right end points? A systematic review of primary outcomes in recent neonatal randomized clinical trials. Journal of Pediatrics. 138:76-80. 2001
- Spontaneous intestinal perforation. Zeitschrift fur Geburtshilfe und Neonatologie. 203:261-263. 1999
- [Spontaneous intestinal perforation in premature infants].. Zeitschrift fur Geburtshilfe und Neonatologie. 203:261-263. 1999
- Methylxanthine therapy in premature infants: Sound practice, disaster, or fruitless byway?. Journal of Pediatrics. 135:526-528. 1999
- Do sick newborn infants benefit from participation in a randomized clinical trial?. Journal of Pediatrics. 134:151-155. 1999
- Diagnostic tests for bacterial infection from birth to 90 days---a systematic review. Archives of Disease in Childhood: Fetal and Neonatal Edition. 78:F92-F98. 1998
- Informed consent for randomised controlled trials in neonates. Archives of Disease in Childhood: Fetal and Neonatal Edition. 78:F156-F156. 1998
- [18F]Fluorodeoxyglucose Uptake in Neonatal Acute Lung Injury Measured by Positron Emission Tomography1. Pediatric Research. 41:892-896. 1997
- The etiology, diagnosis and treatment of thrombotic disorders in newborn infants: A call for international and multi-institutional studies. Seminars in Perinatology. 21:86-89. 1997
- Determinants of Parental Authorization for Involvement of Newborn Infants in Clinical Trials. Pediatrics. 99:e6-e6. 1997
- Does vitamin C cause hemolysis in premature newborn infants? Results of a multicenter double-blind, randomized, controlled trial. Journal of Pediatrics. 130:103-109. 1997
- Thrombin Inhibitors Reduce Intrapulmonary Accumulation of Fibrinogen and Procoagulant Activity of Bronchoalveolar Lavage Fluid During Acute Lung Injury Induced by Pulmonary Overdistention in Newborn Piglets1. Pediatric Research. 39:798-804. 1996
- NEONATAL THROMBOSIS - REPORT OF A PROSPECTIVE CANADIAN AND INTERNATIONAL REGISTRY. Pediatrics. 96:939-943. 1995
- Neonatal thrombosis: report of a prospective Canadian and international registry.. Pediatrics. 96:939-943. 1995
- Precision and Accuracy of Clinical and Radiological Signs in Premature Infants at Risk of Patent Ductus Arteriosus. Archives of Pediatrics and Adolescent Medicine. 149:1136-1136. 1995
- Neonatal Thrombosis: Are We Doing the Right Studies?. Seminars in Thrombosis and Hemostasis. 21:313-316. 1995
- Antithrombin III deficiency in neonatal respiratory distress syndrome. Blood Coagulation and Fibrinolysis. 5:S13-18. 1994
- Panel Discussion. Blood Coagulation and Fibrinolysis. 5:S59-S59. 1994
- Do coagulation screening tests detect increased generation of thrombin and plasmin in sick newborn infants?. Thrombosis and Haemostasis. 69:418-421. 1993
- COAGULATION SCREENING-TESTS IN HIGH-RISK NEONATES - A PROSPECTIVE COHORT STUDY. Archives of Disease in Childhood. 67:1196-1197. 1992
- Coagulation screening tests in high risk neonates: a prospective cohort study.. Archives of Disease in Childhood. 67:1196-1197. 1992
- ON BIRTH-WEIGHT AND COMPLIANCE OF THE RESPIRATORY SYSTEM AS PREDICTORS OF OUTCOME IN INFANTS WITH RESPIRATORY-FAILURE - REPLY. Pediatric Pulmonology. 13:129-129. 1992
- AN ENDEMIC STRAIN OF STAPHYLOCOCCUS-HAEMOLYTICUS COLONIZING AND CAUSING BACTEREMIA IN NEONATAL INTENSIVE-CARE UNIT PATIENTS. Pediatrics. 89:696-700. 1992
- An endemic strain of Staphylococcus haemolyticus colonizing and causing bacteremia in neonatal intensive care unit patients.. Pediatrics. 89:696-700. 1992
- THROMBIN ANTITHROMBIN-III COMPLEX-FORMATION IN THE NEONATAL RESPIRATORY-DISTRESS SYNDROME. American Review of Respiratory Disease. 145:767-770. 1992
- Thrombin Inhibition Is Impaired in Plasma of Sick Neonates. Pediatric Research. 31:391-395. 1992
- Thrombin/Antithrombin III Complex Formation in the Neonatal Respiratory Distress Syndrome. American Review of Respiratory Disease. 145:767-770. 1992
- Report of Scientific and Standardization Subcommittee on Neonatal Hemostasis Diagnosis and Treatment of Neonatal Thrombosis. Thrombosis and Haemostasis. 67:381-382. 1992
- ROLE OF LIPIDS IN THE PATHOGENESIS OF COAGULASE-NEGATIVE STAPHYLOCOCCAL BACTEREMIA IN NEONATES. Pediatric Infectious Disease Journal. 10:168-168. 1991
- Birthweight, early passive respiratory system mechanics, and ventilator requirements as predictors of outcome in premature infants with respiratory failure. Pediatric Pulmonology. 10:195-198. 1991
- Respiratory response and pharmacokinetics of intravenous salbutamol in infants with bronchopulmonary dysplasia. Critical Care Medicine. 18:1374-1377. 1990
- Thrombin generation in newborn plasma is critically dependent on the concentration of prothrombin.. Thrombosis and Haemostasis. 63:27-30. 1990
- Alpha-2-macroglobulin is an important progressive inhibitor of thrombin in neonatal and infant plasma.. Thrombosis and Haemostasis. 62:1074-1077. 1989
- Anticoagulant Effects of Heparin in Neonatal Plasma'. Pediatric Research. 25:405-408. 1989
- Searching MEDLINE for randomized clinical trials involving care of the newborn.. Pediatrics. 83:543-546. 1989
- Heparin clearance and ex vivo recovery in newborn piglets and adult pigs. Thrombosis Research. 52:517-527. 1988
- Standard assays underestimate the concentration of heparin in neonatal plasma.. Journal of Laboratory and Clinical Medicine Translational Research. 112:641-643. 1988
- Antithrombotic Properties of Heparin in a Neonatal Piglet Model of Thrombin-Induced Thrombosis. Thrombosis and Haemostasis. 60:289-292. 1988
- NEONATAL THROMBOTIC DISEASE - PREVENTION, DIAGNOSIS, AND TREATMENT. Journal of Pediatrics. 113:409-410. 1988
- Neonatal thrombotic disease: Prevention, diagnosis, and treatment. Journal of Pediatrics. 113:407-410. 1988
- Fibrinogen Has a Rapid Turnover in the Healthy Newborn Lamb. Pediatric Research. 23:249-252. 1988
- Strengths and limitations of the Apgar score: A critical appraisal. Journal of Clinical Epidemiology. 41:843-850. 1988
- Use of Heparin in Newborn Infants. Seminars in Thrombosis and Hemostasis. 14:28-32. 1988
- Coagulase-negative staphylococci as true pathogens in newborn infants: a cohort study.. Pediatric Infectious Disease Journal. 6:1026-1031. 1987
- Low antithrombin III in neonatal shock: DIC or non-specific protein depletion?. European Journal of Pediatrics. 145:500-503. 1986
- Disseminated intravascular coagulation masking neonatal hemophilia.. Journal of Pediatrics. 109:886-888. 1986
- Thrombotic Disease in Newborn Infants. Clinics in Perinatology. 11:461-488. 1984
-
conference paper
- ACCURACY AND PRECISION OF PULSE OXIMETRY IN HYPOXEMIC INFANTS. European Journal of Pediatrics. 1584-1585. 2016
- OXYGEN SATURATION TARGETING IN EXTREMELY PRETERM INFANTS: THE PROSPECTIVELY PLANNED, NEOPROM INDIVIDUAL PARTICIPANT DATA META-ANALYSIS. European Journal of Pediatrics. 1564-1564. 2016
- The Caffeine for Apnea of Prematurity (CAP) Trial: Preliminary Outcomes at 5 Years. Pediatric Research. 24-24. 2011
- PIH11 ECONOMIC EVALUATION ALONGSIDE THE CAFFEINE FOR APNEA OF PREMATURITY (CAP) TRIAL: SHORT TERM OUTCOMES. Value in Health. A164-A164. 2009
- Caffeine therapy for apnea of prematurity in infants with very low birth weight: Where are we now?. Biology of the Neonate Neonatology. 223-223. 2008
- The international caffeine for apnea of prematurity (CAP) trial: outcomes at 18-21 months. Acta Paediatrica, International Journal of Paediatrics. 233-233. 2007
- 248 Prophylactic Antithrombin to Prevent Intraventricular Haemorrhage in Preterm Infants: A Systematic Review.. Pediatric Research. 397-397. 2005
- 25 Antithrombin for the Treatment of Respiratory Distress Syndrome: A Systematic Review. Pediatric Research. 358-358. 2005
- 234 Surgical Closure of A Patient Ductus Arteriosus (PDA) is Associated with Increased Neuro-Sensory Impairment in Extremely Low Birth Weight (ELBW) Infants: Results from The Trial of Indomethacin Prophylaxis in Preterms. Pediatric Research. 503-503. 2004
- Early prediction of poor outcome in extremely low birth weight (ELBW) infants by classification and regression tree analysis. Pediatric Research. 478A-478A. 2004
- HEat Loss Prevention (HELP) in the delivery room: A randomized clinical trial (RCT) in very preterm infants. Pediatric Research. 374A-374A. 2003
- Motor function in very preterm infants at a corrected age of 18 months: How big is the impact of cerebral palsy?. Pediatric Research. 467A-467A. 2003
- Why does indomethacin prophylaxis prevent patent ductus arteriosus (PDA), but not bronchopulmonary dysplasia (BPD)?. Pediatric Research. 354A-354A. 2003
- Daily cost prediction model for neonatal intensive care. Pediatric Research. 376A-376A. 2002
- Predicting long-term outcome in extremely-low-birth-weight infants: Do we really have to wait until a corrected age of 18 months?. Pediatric Research. 295A-295A. 2002
- Randomised controlled trial of low-dose erythromycin in preterm infants with feed intolerance. Pediatric Research. 379A-380A. 2002
- Retrospective economic evaluation of the controlled trial of indomethacin prophylaxis in preterms (TIPP). Pediatric Research. 379A-379A. 2002
- The GRASP and PRN nurse workload measures correlate well with illness severity (SNAP-II) and therapeutic intensity (NTISS) but MEDICUS does not. Pediatric Research. 374A-374A. 2002
- Early activity of inflammatory cells in the lungs of very low birth weight (VLBW) infants: The effect of in-utero inflammation. Pediatric Research. 351A-351A. 2000
- Factors associated with administration of narcotics (N) to babies receiving assisted ventilation (AV). Pediatric Research. 417A-417A. 2000
- International randomized placebo-controlled trial of indomethacin prophylaxis in preterm infants (TIPP). Pediatric Research. 431A-431A. 2000
- Outcomes with use of narcotics (N) in newborn babies requiring assisted ventilation (AV). Pediatric Research. 368A-368A. 2000
- Risk factors for bronchopulmonary dysplasia (BPD) among infants admitted to 17 neonatal intensive care units (NICUs) in Canada. Pediatric Research. 371A-371A. 2000
- Variations in the site specific rates of bronchopulmonary dysplasia (BPD) among infants admitted to 17 neonatal intensive care units (NICUs) in Canada - Implications for bench marking. Pediatric Research. 371A-371A. 2000
- Do we Measure the Right Endpoints in Neonatal Randomized Clinical Trials (RCTs)?. Pediatric Research. 922-922. 1999
- Adequacy and efficiency of nurse staffing and relationship to patient outcomes and illness severity at four Canadian NICUs. Pediatric Research. 248A-248A. 1999
- Do We Measure the Right Endpoints? A Systematic Review of Primary Outcomes in Recent Neonatal Randomized Clinical Trials. Pediatric Research. 223A-223A. 1999
- Prevalence of Narcotics, Benzodiazepines and Pancuronium Use in Babies Requiring Assisted Ventilation in Canada. Pediatric Research. 252A-252A. 1999
- Variations in Use of Narcotics (N), Benzodiazepins (B), and Pancuronium (P) in Newborn Babies with Assisted Ventilation. Pediatric Research. 313A-313A. 1999
- A triple-blind placebo-controlled randomized trial of antithrombin therapy in neonatal respiratory distress syndrome. Thrombosis and Haemostasis. HI7-HI7. 1997
- Heparin improves gas exchange during experimental acute lung injury in newborn piglets. Thrombosis and Haemostasis. P2341-P2341. 1997
- Incidence and diagnosis of neonatal thrombosis associated with umbilical venous catheters. Thrombosis and Haemostasis. P2953-P2953. 1997
- Determinants of parental authorization for involvement of newborn infants in clinical trials. Pediatrics. E61-E66. 1997
- A feasible model of early chronic lung disease in mechanically ventilated newborn piglets.. Pediatric Research. 1122-1122. 1996
- Determinants of parental authorization for neonatal research involvement.. Pediatric Research. 1517-1517. 1996
- Positron emission tomography (PET) of (11)FDG uptake is an accurate in vivo measure of neonatal acute lung injury. Pediatric Research. 1316-1316. 1996
- Stability of reconstituted induced(R) PDA (indomethacin sodium trihydrate).. Pediatric Research. 468-468. 1996
- Ventilatory management of neonatal pulmonary interstitial emphysema: Results of a Canadian survey.. Pediatric Research. 1919-1919. 1996
- WOULD PARENTS IN THE NICI PREFER TO FORGO CONSENT DECISIONS FOR ENROLLMENT OF THEIR INFANTS IN CLINICAL-TRIALS. Pediatric Research. 463-463. 1995
- NEONATAL THROMBOSIS - ARE WE DOING THE RIGHT STUDIES. Thrombosis and Haemostasis. 1293-1293. 1995
- RECOMBINANT HIRUDIN AMELIORATES ACUTE LUNG INJURY-INDUCED BY MECHANICAL VENTILATION AT HIGH PEAK PRESSURES IN NEWBORN PIGLETS. Thrombosis and Haemostasis. 1296-1296. 1995
- COMPARISON OF PARENTAL RATING OF NEONATAL ILLNESS SEVERITY WITH THE SCORE FOR NEONATAL ACUTE PHYSIOLOGY (SNAP). Pediatric Research. A247-A247. 1995
- DOES VITAMIN-C CAUSE HEMOLYSIS IN PREMATURE NEWBORNS. Pediatric Research. A203-A203. 1995
- WOULD PARENTS IN THE NICU PREFER TO FORGO CONSENT DECISIONS FOR ENROLLMENT OF THEIR INFANTS IN CLINICAL-TRIALS. Pediatric Research. A40-A40. 1995
- A PROSPECTIVE INTERNATIONAL REGISTRY OF NEONATAL THROMBOTIC DISEASES. Pediatric Research. A170-A170. 1994
- PRECISION AND ACCURACY OF CLINICAL SIGNS IN INFANTS AT RISK OF PATENT DUCTUS ARTERIOSUS (PDA). Pediatric Research. 272-272. 1994
- DOES VITAMIN-C CAUSE HEMOLYSIS IN PREMATURE NEWBORNS - RESULTS OF A MULTICENTER, DOUBLE-BLIND, RANDOMIZED, CONTROLLED TRIAL. Blood. A96-A96. 1993
- EFFICACY OF THROMBIN INHIBITION IN A PIGLET MODEL OF NEONATAL ACUTE LUNG INJURY. Thrombosis and Haemostasis. 1020-1020. 1993
- DO COAGULATION SCREENING-TESTS DETECT INCREASED GENERATION OF THROMBIN AND PLASMIN IN SICK NEWBORN-INFANTS. Thrombosis and Haemostasis. 720-720. 1991
- COAGULATION SCREENING-TESTS IN HIGH-RISK NEWBORN-INFANTS - A PROSPECTIVE COHORT STUDY. Pediatric Research. A277-A277. 1991
- COAGULATION SCREENING-TESTS DETECT INCREASED GENERATION OF THROMBIN AND PLASMIN IN SICK NEWBORN-INFANTS. Pediatric Research. A268-A268. 1990
- THROMBIN FORMATION IS INCREASED IN SEVERE NEONATAL RESPIRATORY-DISTRESS SYNDROME (RDS). Pediatric Research. A224-A224. 1990
- THROMBIN GENERATION IN NEWBORN PLASMA IS DEPENDENT ON PROTHROMBIN CONCENTRATION. Arteriosclerosis. A664-A664. 1988
- PASSIVE COMPLIANCE IS A MORE ACCURATE PREDICTOR OF POOR OUTCOME THAN VENTILATOR REQUIREMENTS IN VENTILATED INFANTS. Pediatric Research. 229-229. 1987
- ALPHA-2-MACROGLOBULIN IS A MORE IMPORTANT INHIBITOR OF THROMBIN IN INFANT PLASMA THAN IN ADULT PLASMA. Thrombosis and Haemostasis. 400-400. 1987
- ANTITHROMBOTIC PROPERTIES OF HEPARIN IN A NEONATAL MODEL OF THROMBIN INDUCED VENOUS STASIS THROMBOSIS. Thrombosis and Haemostasis. 218-218. 1987
- HEPARIN HAS A GREATER ANTICOAGULANT EFFECT IN NEONATAL THAN IN ADULT PLASMA. Pediatric Research. A411-A411. 1987
- PHARMACOKINETICS AND RESPIRATORY PHARMACODYNAMICS OF IV SALBUTAMOL IN NEONATES WITH BRONCHOPULMONARY DYSPLASIA. Pediatric Research. A236-A236. 1987
- RED-CELL CHANGES IN NEONATAL SEPSIS. Pediatric Research. A307-A307. 1987
- SEARCHING MEDLINE FOR HIGH-QUALITY STUDIES ON CARE OF THE NEWBORN. Pediatric Research. A365-A365. 1987
- α2-MACROGLOBULIN AND ANTITHROMBIN III ARE EQUALLY IMPORTANT INHIBITORS OF THROMBIN IN NEONATAL PLASMA. Pediatric Research. 306A-306A. 1987
- 138 COAGULASE NEGATIVE STAPHYLOCOCCI (CMS) ARE TRUE PATHOGENS IN NEWBORN INFANTS: A PROSPECTIVE COHORT STUDY. Pediatric Research. 1057-1057. 1986
- ACUTE PHASE PROTEINS (APP) AND IMMATURE TOTAL NEUTROPHIL RATIO (ITNR) IN NEONATAL COAGULASE NEGATIVE STAPHYLOCOCCAL BACTEREMIA (CNSB). Pediatric Research. A393-A393. 1986
- CLINICAL MANIFESTATIONS OF NEONATAL COAGULASE NEGATIVE STAPHYLOCOCCAL BACTEREMIA (CNSB) - A COHORT CONCURRENT STUDY. Pediatric Research. A402-A402. 1986
- PASSIVE COMPLIANCE (CRS) IDENTIFIES INFANTS WITH CHRONIC VENTILATOR DEPENDENCY BY DAY 7 BUT NOT DAY 1. Pediatric Research. A433-A433. 1986
- RESPIRATORY COMPLIANCE DURING THE 1ST WEEK OF LIFE IN VENTILATED INFANTS LESS-THAN-OR-EQUAL-TO 1000-G. Pediatric Research. A433-A433. 1986
- RISK-FACTORS FOR NEONATAL COAGULASE NEGATIVE STAPHYLOCOCCAL BACTEREMIA (CNSB). Pediatric Research. A402-A402. 1986
- INHIBITION OF THROMBIN GENERATION INVITRO REQUIRES LESS HEPARIN IN THE NEWBORN THAN IN THE ADULT. Clinical and Investigative Medicine. A78-A78. 1986
- DECLINE IN RESPIRATORY COMPLIANCE DURING THE FIRST WEEK OF LIFE IN INFANTS ≤ 1000 g. Pediatric Research. 1077-1077. 1985